Akari Therapeutics (AKTX)
NASDAQ: AKTX
· Real-Time Price · USD
1.00
-0.01 (-0.98%)
At close: Aug 18, 2025, 3:58 PM
0.96
-4.00%
After-hours: Aug 18, 2025, 04:10 PM EDT
-0.98% (1D)
| Bid | 0.96 |
| Market Cap | 16.31K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -17.93M |
| EPS (ttm) | -2.58 |
| PE Ratio (ttm) | -0.39 |
| Forward PE | -2.16 |
| Analyst | Buy |
| Ask | 1.1 |
| Volume | 14,448 |
| Avg. Volume (20D) | 26,691 |
| Open | 0.97 |
| Previous Close | 1.01 |
| Day's Range | 0.97 - 1.00 |
| 52-Week Range | 0.85 - 4.22 |
| Beta | 0.23 |
About AKTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AKTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AKTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+20%
Akari Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
